Cargando…
Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research
Measuring systemic chronic inflammatory markers in the blood may be one way of understanding the role of inflammation in breast cancer risk, and might provide an intermediate outcome marker in prevention studies. Here, we present the results of a systematic review of prospective epidemiologic studie...
Autores principales: | Kehm, Rebecca D., McDonald, Jasmine A., Fenton, Suzanne E., Kavanaugh-Lynch, Marion, Leung, Karling Alice, McKenzie, Katherine E., Mandelblatt, Jeanne S., Terry, Mary Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432395/ https://www.ncbi.nlm.nih.gov/pubmed/32731638 http://dx.doi.org/10.3390/ijerph17155445 |
Ejemplares similares
-
Evidence-Based Interventions for Reducing Breast Cancer Disparities: What Works and Where the Gaps Are?
por: Kehm, Rebecca D., et al.
Publicado: (2022) -
Learning from and Leveraging Multi-Level Changes in Responses to the COVID 19 Pandemic to Facilitate Breast Cancer Prevention Efforts
por: Bowen, Deborah J., et al.
Publicado: (2021) -
Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns
por: Lima, Sarah M., et al.
Publicado: (2021) -
40 Years of Change in Age- and Stage-Specific Cancer Incidence Rates in US Women and Men
por: Kehm, Rebecca D, et al.
Publicado: (2019) -
Do current family history-based genetic testing guidelines contribute to breast cancer health inequities?
por: Jakuboski, Samantha H., et al.
Publicado: (2022)